Oscar Health lifts 2026 earnings outlook to $600–800M
Oscar Health raises its 2026 earnings outlook and modestly improves its medical loss ratio guidance while reaffirming revenue and SG&A targets.
Rhea-AI Filing Summary
Oscar Health, Inc. (OSCR) announced updated full year 2026 guidance in connection with its Investor Day, including higher expected profitability and slightly improved medical cost ratios. The company now expects Earnings from Operations between $600 million and $800 million, up by $100 million from the prior range of $500 million to $700 million.
Oscar also tightened its expected Medical Loss Ratio to 81.0%–82.0%, improving this range by 50 basis points from its previous 81.5%–82.5% outlook. The company reaffirmed its 2026 guidance for Total Revenue of $18.7 billion to $19.0 billion and an SG&A Expense Ratio of 15.6%–16.1%. Management plans to discuss strategy, long-term financial targets, and this updated outlook at its September 16, 2026 Investor Day, with materials and a webcast available on its investor relations website.
Positive
- Earnings from Operations guidance increased to $600–$800 million, up from $500–$700 million, signaling stronger expected profitability for full year 2026.
- Guided Medical Loss Ratio improves by 50 basis points to 81.0%–82.0%, indicating an expectation of better control over medical costs in 2026.
- Oscar reaffirms substantial 2026 revenue guidance of $18.7–$19.0 billion, supporting expectations for continued scale.
- The SG&A Expense Ratio guidance of 15.6%–16.1% is reaffirmed, suggesting operating expense discipline alongside growth.
Negative
- None.
8-K Event Classification
Item 7.01 — Regulation FD Disclosure
1 item
Item 7.01
Regulation FD Disclosure
Disclosure
Material non-public information disclosed under Regulation Fair Disclosure, often investor presentations or guidance.
Key Figures
Earnings from Operations guidance: $600–$800 million
Medical Loss Ratio guidance: 81.0%–82.0%
Total Revenue guidance: $18.7–$19.0 billion
+3 more
6 metrics
Earnings from Operations guidance
$600–$800 million
Full year 2026 updated guidance, increased from $500–$700 million
Medical Loss Ratio guidance
81.0%–82.0%
Full year 2026; improved by 0.50 percentage points from 81.5%–82.5%
Total Revenue guidance
$18.7–$19.0 billion
Full year 2026, reaffirmed
SG&A Expense Ratio guidance
15.6%–16.1%
Full year 2026, reaffirmed
Investor Day start time
9:00 a.m. Eastern Time
September 16, 2026 Investor Day event
Webcast archive duration
90 days
Period webcast will remain available after September 16, 2026
Key Terms
Medical Loss Ratio, Earnings from Operations, SG&A Expense Ratio, forward-looking statements, +1 more
5 terms
Medical Loss Ratio financial
"Medical Loss Ratio between 81.0% and 82.0%"
Medical loss ratio is the share of health insurance premiums that a plan spends on patient care and activities that improve care quality, rather than on administration, marketing, or profit. Think of it like a household budget showing how much of your paycheck goes to groceries versus overhead and discretionary items; a higher ratio means more money is going to care. For investors, the metric signals an insurer’s cost efficiency, pricing pressure and potential regulatory or rebate risk, all of which affect profitability and future cash flow.
Earnings from Operations financial
"Earnings from Operations between $600 million and $800 million"
Earnings from operations is the profit a company generates from its core business activities—sales minus the regular costs to produce and sell goods or services—before counting interest, taxes and one-time gains or losses. It matters to investors because it shows how well the underlying business performs on a day-to-day basis, like judging a restaurant by food sales rather than by occasional property sales or loan deals.
SG&A Expense Ratio financial
"SG&A Expense Ratio between 15.6% and 16.1%"
Selling, general and administrative (SG&A) expense ratio measures the share of a company's sales that is spent on overhead items like sales staff, advertising, rent and office costs, calculated by dividing SG&A expenses by total revenue. Investors use it to judge how efficiently a business turns sales into profit — like checking what portion of a household’s income goes to recurring bills — and to compare cost control across companies or over time.
forward-looking statements regulatory
"contains forward-looking statements within the meaning of the Private Securities"
Forward-looking statements are predictions or plans that companies share about what they expect to happen in the future, like estimating sales or profits. They matter because they help investors understand a company's outlook, but since they are based on guesses and assumptions, they can sometimes be wrong.
Risk Factors regulatory
"the factors set forth under the caption “Risk Factors” in our Annual Report"
Risk factors are elements or conditions that could cause an investment's value to decrease or lead to potential losses. They are like warning signs or obstacles that can affect the success of an investment, making it uncertain or more unpredictable. Recognizing risk factors helps investors understand the possible challenges and make more informed decisions.
Earnings Snapshot
Earnings from Operations guidance: $600–$800 million · Guidance included
Full year 2026 guidance
Earnings from Operations guidance
$600–$800 million
Increased from $500–$700 million
Medical Loss Ratio guidance
81.0%–82.0%
Improved from 81.5%–82.5%
Total Revenue guidance
$18.7–$19.0 billion
Reaffirmed
SG&A Expense Ratio guidance
15.6%–16.1%
Reaffirmed
Guidance
Oscar Health provided updated full year 2026 guidance, raising its Earnings from Operations outlook, modestly improving its Medical Loss Ratio range, and reaffirming both total revenue and SG&A expense ratio targets.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What 2026 earnings guidance did Oscar Health (OSCR) update in this 8-K?
Oscar Health now expects Earnings from Operations between $600 million and $800 million for full year 2026, an increase of $100 million from its previous guidance range of $500 million to $700 million.
How did Oscar Health (OSCR) change its 2026 Medical Loss Ratio outlook?
Oscar updated its 2026 Medical Loss Ratio guidance to 81.0%–82.0%, improving it by 50 basis points from the prior range of 81.5%–82.5%, indicating a small expected improvement in medical cost performance.
What revenue guidance for 2026 did Oscar Health (OSCR) reaffirm?
Oscar reaffirmed its full year 2026 Total Revenue guidance of $18.7 billion to $19.0 billion, maintaining its previously communicated outlook for top-line performance.
What SG&A Expense Ratio is Oscar Health (OSCR) targeting for 2026?
For 2026, Oscar continues to expect an SG&A Expense Ratio between 15.6% and 16.1%, reaffirming its prior guidance for selling, general, and administrative expenses as a percentage of revenue.
What is the purpose of Oscar Health’s 2026 Investor Day mentioned in the 8-K?
Oscar’s 2026 Investor Day on September 16, 2026 will cover its strategy, long-term financial targets, and updated 2026 financial guidance, with a live webcast and materials accessible via the company’s investor relations website.
Where can investors access Oscar Health (OSCR) Investor Day materials?
A live webcast and associated materials will be available on Oscar’s investor relations website (ir.oscarhealth.com), and the webcast will be archived there for 90 days after September 16, 2026.
AI-generated analysis. How Rhea-AI works. Not financial advice.
